Want to join the conversation?
In 1Q16, operating cash flows were $850MM and $TRV ended the quarter with holding company liquidity of over $1.7Bil. Net unrealized investment gains were approx. $2.7Bil pretax or $1.8Bil after-tax. $TRV returned $790MM of capital to shareholders. $TRV paid dividends of $181MM and repurchased $609MM of common shares.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.